Study on Gynecological Rare Cancers
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: chemotherapy, surgery.
- Who it may be relevant to
- Registry conditions: Gynecologic Cancer. Basic parameters: No limits · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Prospective, Multicenter, Observational Study on Rare Gynecological Cancers
Overview
This is a prospective, observational, multicenter study on gynecological rare tumors.
Detailed description
This is a prospective registry aimed to better understand prognosis, clinical and pathological features, management of this rare cancer conditions for improving standard of care.
Interventions
- Other chemotherapy, surgery
this is an observational prospective study, therefore no intervention is planned. Patients perform medical and surgical treatment as per standard of case.
Primary outcome measures
- Prevalence of gynecologic rare malignancies [Time frame: 5 years]
Eligibility criteria
Inclusion criteria
- rare gynecological malignancies
- written informed consent
- patient fit for follow-up
Exclusion criteria
-written informed consent not provided
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Italy · 2 centers
- Ginecologia e Ostetricia, IRCCS Ospedale San Raffaele — Milan
- IRCCS Fondazione G Pascale — Naples
Identifiers
NCT: NCT05733806 · MITO 9B